A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

• Status: Completed
• Trial end date: 2016-09-26
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the effects of ticagrelor and clopidogrel in patients with Peripheral Artery Disease.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Clopidogrel; Ticagrelor; Ticlopidine

Criteria

Inclusion Criteria:

• Male and Female patients 50 years old or older Symptomatic peripheral artery disease

Exclusion Criteria:

• Patients needing dual anti-platlet drug treatment before start of study Planned revascularisation or amputation

• Patients with known bleeding disorders

• Patients with a history of intracranial bleed

• Patients considered to be at risk of bradycardic events unless already treated with a permanent pacemaker